Abstract Background Psoriatic arthritis (PsA) is a distinct inflammatory arthritis occurring in 30% of psoriasis patients. There is a high prevalence of undiagnosed PsA in psoriasis patients; therefore, identifying soluble biomarkers for PsA could help in screening psoriasis patients for appropriate referral to a rheumatologist. Potential PsA biomarkers likely originate in sites of inflammation, such as the skin, and subsequently enter systemic circulation. Our goal was to identify candidate PsA biomarkers by comparing the proteome of skin biopsies obtained from patients with PsA to that from patients with psoriasis without PsA. Methods ...
Psoriasis is an immune-mediated skin disease which affects 2-4% of the worldwide population. Approxi...
ImportanceWhile "omics" studies have advanced our understanding of inflammatory skin diseases, metab...
Background : Psoriasis is a common, chronic, recurrent, inflammatory disease of the skin characteriz...
Abstract Background Psoriatic arthritis (PsA) is a di...
There is a high prevalence of undiagnosed PsA in psoriasis patients; therefore identifying soluble b...
Psoriatic arthritis (PsA) is an inflammatory arthritis which develops in up to one-third of patients...
Abstract Background Synovial fluid (SF) is a dynamic ...
Abstract Background Biomarkers for distinguishing psoriatic arthritis (PsA) from psoriasis without a...
BACKGROUND Biomarkers for distinguishing psoriatic arthritis (PsA) from psoriasis without arthrit...
Biological therapies, which include antitumour necrosis factor-α and T-cell inhibitors, are potentia...
Aim: Psoriatic arthritis (PsA) is an inflammatory arthritis of unknown etiology that develops in app...
Psoriasis has been thought to be driven primarily by innate and adaptive immune systems that can be ...
Psoriatic disease (PsD) is a spectrum of diseases that affect both skin [cutaneous psoriasis (PsC)] ...
pathogenesis are not fully understood and might be elucidated by identifying novel disease-related m...
PURPOSE: To identify candidate biomarkers that have the potential to distinguish between patients wi...
Psoriasis is an immune-mediated skin disease which affects 2-4% of the worldwide population. Approxi...
ImportanceWhile "omics" studies have advanced our understanding of inflammatory skin diseases, metab...
Background : Psoriasis is a common, chronic, recurrent, inflammatory disease of the skin characteriz...
Abstract Background Psoriatic arthritis (PsA) is a di...
There is a high prevalence of undiagnosed PsA in psoriasis patients; therefore identifying soluble b...
Psoriatic arthritis (PsA) is an inflammatory arthritis which develops in up to one-third of patients...
Abstract Background Synovial fluid (SF) is a dynamic ...
Abstract Background Biomarkers for distinguishing psoriatic arthritis (PsA) from psoriasis without a...
BACKGROUND Biomarkers for distinguishing psoriatic arthritis (PsA) from psoriasis without arthrit...
Biological therapies, which include antitumour necrosis factor-α and T-cell inhibitors, are potentia...
Aim: Psoriatic arthritis (PsA) is an inflammatory arthritis of unknown etiology that develops in app...
Psoriasis has been thought to be driven primarily by innate and adaptive immune systems that can be ...
Psoriatic disease (PsD) is a spectrum of diseases that affect both skin [cutaneous psoriasis (PsC)] ...
pathogenesis are not fully understood and might be elucidated by identifying novel disease-related m...
PURPOSE: To identify candidate biomarkers that have the potential to distinguish between patients wi...
Psoriasis is an immune-mediated skin disease which affects 2-4% of the worldwide population. Approxi...
ImportanceWhile "omics" studies have advanced our understanding of inflammatory skin diseases, metab...
Background : Psoriasis is a common, chronic, recurrent, inflammatory disease of the skin characteriz...